Drug Screening Market Study Explores Industry Growth Toward $19.2 Billion

The drug screening market is poised for impressive growth in the coming years, driven by technological advancements and expanding regulatory requirements. This sector is evolving rapidly as new innovations and increasing demand for efficient, accurate testing solutions reshape its landscape. Let's explore the market size projections, key players, emerging trends, and segmentation details shaping the future of drug screening.

Projected Expansion and Market Size of the Drug Screening Market
The global drug screening market is expected to expand significantly, reaching a value of $19.2 billion by 2030. This growth reflects a robust compound annual growth rate (CAGR) of 14.5%. Several factors contribute to this upward trajectory, including the rising use of AI-powered screening analytics, increasing preference for portable drug testing devices, the broadening scope of regulatory drug compliance testing, the adoption of real-time reporting systems, and innovations in multi-panel drug screening technology. Key trends anticipated during the forecast period involve the growing popularity of rapid drug testing kits, wider implementation of automated laboratory screening systems, enhanced digital reporting solutions, greater focus on point-of-care drug testing, and improvements in detection accuracy.

Download a free sample of the drug screening market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Prominent Players Leading the Drug Screening Industry
The drug screening market features a range of influential companies that shape its competitive landscape. Leading organizations include Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, and Eurofins Scientific SE.

Strategic Acquisition Enhancing Premier Biotech's Market Position
In June 2024, Premier Biotech, a United States-based company specializing in urine and oral fluid drug testing and toxicology services, acquired Desert Tox, LLC for an undisclosed sum. This acquisition is aimed at expanding Premier Biotech's laboratory testing capabilities, strengthening its foothold in the oral-fluid drug testing segment, and broadening its national customer base across sectors such as workplace, government, and occupational health. Desert Tox, LLC is recognized as a US provider of SAMHSA-certified urine and oral-fluid drug testing services catering to employment, government, and clinical clients.

View the full drug screening market report:
https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Key Drivers Spurring Growth in the Drug Screening Market
One major factor propelling the drug screening market is the increasing adoption of AI-enabled analytics, which enhances testing efficiency and accuracy. These technologies streamline the screening process and allow for more detailed and timely analysis.
Another important driver is the rising demand for portable drug testing devices. Their convenience and ease of use in various settings, from workplaces to law enforcement, contribute to their growing popularity. Regulatory expansion and compliance requirements also play a significant role in encouraging adoption of advanced screening solutions.

Emerging Trends Offering New Opportunities in Drug Screening
Industry players are placing considerable emphasis on strategic partnerships to strengthen their product offerings and market reach. Such collaborations help companies leverage complementary strengths while remaining independent entities.
For example, in February 2025, Canadian drug testing firm Neopharma Technologies partnered with US-based cognitive assessment company Impairment Science. This alliance merges Neopharma's NEOVAULT platform, which digitally captures and reports rapid drug test outcomes, with Impairment Science's DRUID AI-powered cognitive impairment evaluation tool. Through this integration, the partnership aims to deliver real-time insights not only on drug presence but also on functional impairment, potentially improving workplace safety, regulatory adherence, and decision-making in safety-sensitive environments.

Overview of Market Segments Covered in the Drug Screening Report
The drug screening market is analyzed across several key segments:
1) Products: Rapid Testing Devices, Consumables, and Other Products
2) Sample Types: Oral Fluid, Hair, Urine, Breath, and other sample categories
3) End Users: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, and Educational Institutions such as Schools and Colleges

Detailed subcategories include:
- Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips
- Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards
- Other Products: Laboratory Equipment, Software Solutions, and Storage and Transport Solutions

This comprehensive segmentation helps provide an in-depth understanding of the drug screening market's diverse range of products, user groups, and testing methods.

Our 2026 market reports now offer broader strategic coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.